In its inaugural year, the Lighthouse Beacon Foundation Endowment has made $160,000 in funds available for distribution, with a priority on research support.
Wayne Tuckson, and panel of medical experts examine the topic of dementia and Alzheimer’s disease, discussing the latest on treatments, screenings and resources.
UK Markey Cancer Center’s Molecular Tumor Board identified possible hereditary genetic mutations in 12% of patients with cancer who underwent tumor DNA testing.
This “UK at the Half” features two students who were selected as CURE Fellows to develop new knowledge and skills through research within UK’s Research Priority Areas.
